23 maart 2020
Today, VIVAT has been informed that Athora received a DNO from De Nederlandsche Bank (DNB) for the Transaction. The closing of the Transaction is expected in early April 2020. NN has also received a DNO from DNB in relation to its follow-on acquisition of VIVAT Non-Life.
Today’s approval follows earlier clearances including approval from the European Commission for Athora’s acquisition of VIVAT and from the Netherlands Authority for Consumers and Markets (ACM) for the acquisition of VIVAT Non-Life by NN. In addition, the VIVAT works council has rendered its positive advice regarding the Transaction and the acquisition of VIVAT Non-Life by NN.
VIVAT announces the appointment of three new members to the Executive Board of VIVAT and the boards of VIVAT’s insurance subsidiaries, SRLEV NV and Proteq Levensverzekeringen NV.
Angelo Sacca will be appointed as Chief Strategy & Commercial Officer and Stefan Spohr as Chief Operating Officer as of the Closing Date. Annemarie Mijer-Nienhuis will be appointed as Chief Risk Officer effective on a date after the Closing Date. On 26 February 2020, VIVAT announced that Tom Kliphuis was appointed as CEO effective as per 1 April.
Xiao Wei (Charlene) Wu, Wendy de Ruiter-Lörx, Lan Tang and Jeroen Potjes will resign from the Executive Board of VIVAT and the boards of VIVAT’s insurance subsidiaries as of the Closing Date.
As a result, the Executive Board of VIVAT and the boards of VIVAT’s insurance subsidiaries will be composed of the following persons:
Het Exelerating platform helpt u om inzicht te krijgen in meer dan € 6.000 miljard Europees institutioneel belegd vermogen. Wij doen dit door duizenden openbare bronnen van institutionele beleggers te volgen en te analyseren.
Lees meer